SANTA ANA, Calif., April 28, 2011 /PRNewswire/ -- AquaStar Holdings, Inc. (Pink Sheets: RPPR) is pleased to announce that the United States Patent and Trademark Office has issued patent number 7,708,944 for the Ultra-Sensitive, Portable Capillary Sensor technology utilized by the Capwave Enzyme-Linked Immuno-Sorbent Assay (ELISA) platform.
The patent, entitled "Ultra-Sensitive, Portable Capillary Sensor" details research completed at the State University of New York Binghamton supported in part by grants from the United States Environmental Protection Agency and IEEC/National Science Foundation. The patent method is the essence of the rapid, sensitive, and portable Enzyme-Linked ImmunoSorbent Assay (ELISA) platform Capwave technology, which enables the user to quickly detect Bioweapons (anthrax, bacillus globigii), Biomarkers (cancer, stem cells), Toxins (E. coli and salmonella in foodborne illness), Contaminants and Diseases (both viral and bacterial).
"We are very pleased with the progress being made toward the commercial offering of the Capwave technology. Obviously, gaining protection for the intellectual property is an important step in the process," stated Malcolm Lennie, President of AquaStar Holdings, Inc.
In further news, the Company recently announced that its client's Capwave licensed technology has received over $600,000 in federal research grants from the U.S. Government. The State University of New York (SUNY) Binghamton has confirmed that the U.S. Army Research Office, the U.S. Army Research Development & Engineering Command, the EPA and the National Research Council have contributed over $618,000 in total funding to benefit the Research and Development of Capwave's portable Enzyme-Linked Immuno-Sorbent Assay (ELISA) platform technology.
For more information on SUTIMCo, its portfolio companies, and University partners, please visit; http://www.suti.com
About AquaStar Holdings, Inc.:
AquaStar Holdings, Inc. is a holding company, which utilizes a unique and established platform to launch new technology enterprises based on world-class university research discoveries. AquaStar Holdings, through its wholly owned subsidiary SUTIMCo, Inc., provides experienced management to early stage companies, reducing risk and assuring the know-how in launching and growing a new company. In addition to this skilled management team, AquaStar Holdings can avail itself of the encyclopedic, informal knowledge of the inventor, his experience and his research team.
Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results
SOURCE AquaStar Holdings, Inc.